2d, just curious as to why Ariad with its myriad of scientists, business people (inside/outside analysts), all the data from their own trials, the data from independent clinical trials, Alex Denner, Harvey Berger, Paris P., why do you think they haven't adopted your approach/idea yet to abandon the quest for the OPTIC trials and instead focus their business on the current label of Iclusig, which you said will generate a better perspective for the stock than the former? To me that's an implication that all these collection of people don't know what they are doing, what say ye?